Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2013-10-24

Clinical Trial Update: Gene Therapy for Prostate Cancer That Returns After Radiation Therapy [Phase 1]

View source ↗

Summary

A Phase 1 gene therapy trial for prostate cancer that recurs after radiation therapy has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Simon Hall | Conditions: Prostatic Neoplasms, Neoplasm Recurrence, Local | Phase 1 | Status: WITHDRAWN